X1000306-1982-83_Part03 — Page 3

Medical and Health Departmental Reports 醫務衛生署年報 All

TABLE 44 (Cont'd)

Tabu-

lation

List

Number

Detailed

Number of In-patients Treated (including deaths)

All deaths in

Hong Kong

List No.

Cause Groups

1975

Revision

Govt.

G-Asst. Private Hosp. Hosp. Hosp.

Total

Male Female Total

T097

156,158,

159

}

TLOO

161

Brought forward Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneus Malignant neoplasm of larynx

25,472 13,078

7,040

45,590

2,619, 1,218

3,837

185

207

77

469

82

81

163

509

206

69

784

85

11

T101

162

Malignant neoplasm of trachea,

3,406

2,664

1,172

7,242

1,263

699

96

1,962

bronchus and lung

T102

163-165)

160, Malignant neoplasm of other and ill-

defined sites within the respiratory system and intrathoracic organs

100

TLIQ

170

Malignant neoplasm of bone and

199

articular cartilage

T111

171

Malignant neoplasm of connective and other soft tissue

100

7112

172

Malignant melanoma of skin

56

T113

173

T114

174

T115

175

T120

180

T121

181

Other malignant neoplasm of skin Malignant neoplasm of female breast Malignant neoplasm of male breast Malignant neoplasm of cervix uteri Malignant neoplasm of placenta

65

783

8

1,417

19

T122

179, 182

Malignant neoplasm of uterus, other and unspecified

182

125

T123

183

Malignant neoplasm of ovary and other

469

114

uterine adnexa

T124

185

Malignant neoplasm of prostate

126

127

T125

186

Malignant neoplasm of testis

67

T126

T127

188

Malignant neoplasm of bladder

184,187,)

189 )

Malignant neoplasm of other and

846 506

280

unspecified genitourinary organs Carried forward

136 68

34,295 18,549 9,684 62,528

58-5 = 5.86*W * * *

8A8 3 2, ANG== * & 8

206

23

14

37

317

32

11

43

148

10

3

13

106

8

122

415

245

2,044

202

16

2

1,918

108

20

383

སནྡྷསྶདྡྷgg

2

10

5

9

202

2

108

35

35

670

77

77

321

53

3

81

5

255

1,607

83

40

484

38

31

LISA

53

5

123

69

4,307 | 2,537

6,844

TABLE 44 (Cont'd)

Tabu-

lation

List

List No.

Number

Detailed

1975

Revision

Number of In-patients Treated (including deaths)

All deaths in Hong Kong

Cause Groups

Govt. G-Asst. Hosp. Hosp.

Private

Hosp.

Total

Male

Female

Total

T130

191

Brought forward

Malignant neoplasm of brain

34,295 | 18,549

9,684

69

134

30

62,528

233

4,307

2,537

6,844

53

49

102

T131

190,

192-199 )

) Malignant neoplasm of other and unspecified sites

691

415

225

1,331

178

129

307

T140

201

Hodgkin's disease

83

12

T141

200,202,

Other malignant neoplasm of lymphatic

1,148

201

87

98

1,436

6

10

100

74

174

203

tissue

7142

204-208

Leukaemia

1,281

T150

210-229

Benign neoplasm

2,366

T160

230-234

Carcinoma in situ

46

T170

235-239

Other and unspecified neoplasm

621

གྷཉྫུསྨིཾ

99

52

1,432

89

67

156

2,730 2,430 7,526

12

17

14

145

205

352

70

1,043

T180

240, 241

Non-toxic goitre

473

368

138

979

T181

242

Thyrotoxicosis with or without goitre

508

199

206

913

T182

243-246

Other disorders of thyroid gland

211

136

346

693

T183

250

Diabetes mellitus

3,724 2,936

938

7.598

79

124

203

T184

272

Disorders of lipoid metabolism

14

16

40

70

T185

278

Obesity and other hyperalimentation

34

11

1

46

T186

251-259,

270,271,) Other endocrine, metabolic and

273-277,) immunity disorders

1,097

285

202

1,584

7

29

279 }

T190

260-263

T191

T200

T201 T202 282-285

264-269

Kwashiorkor, nutritional marasmus and other protein-calorie malnutrition Avitaminosis

19

16

3

38

I

33

8

1

42

1

280

Iron deficiency anaemias

38

108

110

256

281

Other deficiency anaemias

14

83

59

156

Other anaemias

2,908

549

338 3,795

14

T203

286-289

Other diseases of blood and

1,787

237

blood-forming organs

Carried forward

51,460 | 27,458

164

15,272

2,188

7

94,190 4,837

3,013

7,850

Comments

Approved members can add comments, bookmarks, and private notes.

No comments yet.

Private Research Note

Private notes are available after approval.